NIFTY 50
24,649.55 (-0.30%)
NIFTY IT
35,034.50 (-0.48%)
NIFTY AUTO
23,876.30 (0.37%)
NIFTY FINANCIAL SERVICES
26,373.50 (-0.39%)
NIFTY BANK
55,360.25 (-0.47%)
NIFTY REALTY
907.85 (-0.46%)
NIFTY ENERGY
34,914.40 (-0.03%)
NIFTY METAL
9,336.05 (0.09%)
NIFTY FMCG
55,733.70 (-0.72%)
NIFTY HEALTH CARE
14,481.55 (-0.48%)
NIFTY PHARMA
21,970.15 (-0.83%)
NIFTY MEDIA
21,970.15 (-0.83%)
Trend of Stock Market

A trend is the broad upward or downward movement of a stock's price over time

   Quarterly Results
Change Company Name
Dr Reddys Laboratories Ltd
Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code 500124 ISIN Demat INE089A01031 Book Value 345.76 NSE Symbol DRREDDY Dividend Yield (%) 0.65 Market Cap ( Cr.) 102,269.65 P/E 14.84 EPS 82.6 Face Value 1

Particulars (₹ Cr)Jun 2025Mar 2025Dec 2024Sep 2024
Gross Sales/Income from operations 7788.75546.34997.86678.8
Less: Excise duty 0.000.000.000.00
Net Sales/Income from operations 7,788.705,546.304,997.806,678.80
Other Operating Income 20.8016.6017.2017.50
Total Income from operations (net) 7,809.505,562.905,015.006,696.30
Total Expenses 4,252.304,384.404,087.704,234.70
Cost of Sales 1,586.401,559.501,483.101,497.80
Employee Cost 887.30797.10794.40840.10
Depreciation, amortization and depletion expense 279.80264.50265.10260.00
Provisions & Write Offs 0.00103.600.000.00
Administrative and Selling Expenses 0.000.000.000.00
Other Expenses 1,498.801,659.701,545.101,636.80
Pre Operation Expenses Capitalised 0.000.000.000.00
Profit from operations before other income, finance costs and exceptional items 3,557.201,178.50927.302,461.60
Other Income 398.30414.40235.40207.60
Profit from ordinary activities before finance costs and exceptional items 3,955.501,592.901,162.702,669.20
Finance Costs 19.2031.1043.3028.40
Profit from ordinary activities after finance costs but before exceptional items 3,936.301,561.801,119.402,640.80
Exceptional Items 0.000.000.000.00
Other Adjustments Before Tax 0.000.000.000.00
Profit from ordinary activities before tax 3,936.301,561.801,119.402,640.80
Total Tax 975.10361.10270.00758.70
Net profit from Ordinary Activities After Tax 2,961.201,200.70849.401,882.10
Profit / (Loss) from Discontinued Operations 0.000.000.000.00
Net profit from Ordinary Activities/Discontinued Operations After Tax 2,961.201,200.70849.401,882.10
Extraordinary items 0.000.000.000.00
Other Adjustments After Tax 0.000.000.000.00
Net Profit after tax for the Period 2,961.201,200.70849.401,882.10
Other Comprehensive Income 18.5070.60-58.30-6.60
Total Comprehensive Income 2,979.701,271.30791.101,875.50
Equity 83.5083.4083.4083.40
Reserve & Surplus 0.000.000.000.00
Face Value 1.001.001.005.00
EPS:     
EPS before Exceptional/Extraordinary items-Basic 35.5914.4110.20113.00
EPS before Exceptional/Extraordinary items-Diluted 35.5414.3910.18112.80
EPS after Exceptional/Extraordinary items-Basic 35.5914.4110.20113.00
EPS after Exceptional/Extraordinary items-Diluted 35.5414.3910.18112.80
Book Value (Unit Curr.) 0.000.000.000.00
Dividend Per Share(Rs.) 0.000.000.000.00
Dividend (%) 0.000.000.000.00
No. of Employees 0.000.000.000.00
Debt Equity Ratio 0.000.000.000.00
Debt Service Coverage Ratio 0.000.000.000.00
Interest Service Coverage Ratio 0.000.000.000.00
Debenture Redemption Reserve (Rs cr) 0.000.000.000.00
Paid up Debt Capital (Rs cr) 0.000.000.000.00
  • Copyright © 2024   INVES 21
  • Designed, developed and Content Provide by CMOTS Infotech (ISO 9001:2015 certified)